Literature DB >> 6207398

Modulation of HLA-DR antigens expression in human myeloid leukaemia cells by cytarabine and 5-aza-2'-deoxycytidine.

A Pinto, M Maio, V Attadia, S Zappacosta, R Cimino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6207398     DOI： 10.1016/s0140-6736(84)90900-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  23 in total

1.  Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study.

Authors:  Marcos de Lima; Sergio Giralt; Peter F Thall; Leandro de Padua Silva; Roy B Jones; Krishna Komanduri; Thomas M Braun; Hoang Q Nguyen; Richard Champlin; Guillermo Garcia-Manero
Journal:  Cancer       Date:  2010-07-29       Impact factor: 6.860

Review 2.  Hypomethylating agents after allogeneic blood stem cell transplantation.

Authors:  Thomas Schroeder; Christina Rautenberg; Rainer Haas; Guido Kobbe
Journal:  Stem Cell Investig       Date:  2016-11-28

Review 3.  Hypomethylating agents for treatment and prevention of relapse after allogeneic blood stem cell transplantation.

Authors:  Thomas Schroeder; Christina Rautenberg; Rainer Haas; Ulrich Germing; Guido Kobbe
Journal:  Int J Hematol       Date:  2017-11-15       Impact factor: 2.490

4.  Clonal evolution and immune evasion in posttransplantation relapses.

Authors:  Luca Vago
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

5.  Azacitidine salvage therapy for relapse of myeloid malignancies following allogeneic hematopoietic SCT.

Authors:  B Tessoulin; J Delaunay; P Chevallier; M Loirat; S Ayari; P Peterlin; S Le Gouill; T Gastinne; P Moreau; M Mohty; T Guillaume
Journal:  Bone Marrow Transplant       Date:  2014-02-03       Impact factor: 5.483

Review 6.  Emerging therapies in hematopoietic stem cell transplantation.

Authors:  Pavan Reddy; Marcos de Lima; John Koreth
Journal:  Biol Blood Marrow Transplant       Date:  2012-01       Impact factor: 5.742

7.  5-azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantation.

Authors:  Javier Bolaños-Meade; B Douglas Smith; Steven D Gore; Michael A McDevitt; Leo Luznik; Ephraim J Fuchs; Richard J Jones
Journal:  Biol Blood Marrow Transplant       Date:  2010-10-15       Impact factor: 5.742

8.  Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia.

Authors:  Elias Jabbour; Sergio Giralt; Hagop Kantarjian; Guillermo Garcia-Manero; Madan Jagasia; Partow Kebriaei; Leandro de Padua; Elizabeth J Shpall; Richard Champlin; Marcos de Lima
Journal:  Cancer       Date:  2009-05-01       Impact factor: 6.860

Review 9.  Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.

Authors:  Raya Mawad; Jack M Lionberger; John M Pagel
Journal:  Curr Hematol Malig Rep       Date:  2013-06       Impact factor: 3.952

10.  Differentiation of human leukaemic cell lines and fresh leukaemia cells by low dose Ara-C: monitoring by expression of c-myc and c-fos oncogenes.

Authors:  A Pinto; V Attadia; R Rosati; G Colletta; R Cimino; A Colombatti
Journal:  Med Oncol Tumor Pharmacother       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.